-
Comparisons of cardioprotective efficacy between fibroblast growth factor 21 and dipeptidyl peptidase-4 inhibitor in prediabetic
rats
Pongpan Tanajak, Piangkwan Sa-nguanmoo, Nattayaporn Apaijai, Xiaojie Wang, Guang Liang, Xiaokun Li, Chao Jiang, Siriporn C.
Chattipakorn, and Nipon Chattipakorn
Cardiovascular Therapeutics
(2017)
35 :e12263
-
Cardioprotection of dapagliflozin and vildagliptin in rats with cardiac ischemia-reperfusion injury
Pongpan Tanajak, Piangkwan Sa-nguanmoo, Sivaporn Sivasinprasasn, Savitree Thummasorn, Natthaphat Siri-Angkul, Siriporn C Chattipakorn,
and Nipon Chattipakorn
Journal of Endocrinology
(2018)
236 :69
-
Increased plasma FGF21 level as an early biomarker for insulin resistance and metabolic disturbance in obese insulin-resistant
rats
Pongpan Tanajak, Wanpitak Pongkan, Siriporn C Chattipakorn, and Nipon Chattipakorn
Diabetes and Vascular Disease Research
(2018)
:147916411875715
-
Differential associations of lower cardiac vagal tone with insulin resistance and insulin secretion in recently diagnosed
type 1 and type 2 diabetes
Dan Ziegler, Alexander Strom, Gidon Bönhof, Sonja Püttgen, Kálmán Bódis, Volker Burkart, Karsten Müssig, Julia Szendroedi,
Daniel F. Markgraf, and Michael Roden
Metabolism
(2018)
79 :1
-
Dipeptidyl Peptidase-4 Inhibitor, Vildagliptin, Improves Trabecular Bone Mineral Density and Microstructure in Obese, Insulin-Resistant,
Pre-diabetic Rats
Narattaphol Charoenphandhu, Panan Suntornsaratoon, Piangkwan Sa-Nguanmoo, Pongpan Tanajak, Jarinthorn Teerapornpuntakit, Ratchaneevan
Aeimlapa, Nipon Chattipakorn, and Siriporn Chattipakorn
Canadian Journal of Diabetes
(2018)
:
-
FGF21 and DPP-4 inhibitor equally prevents cognitive decline in obese rats
Piangkwan Sa-nguanmoo, Pongpan Tanajak, Sasiwan Kerdphoo, Thidarat Jaiwongkam, Xiaojie Wang, Guang Liang, Xiaokun Li, Chao
Jiang, Wasana Pratchayasakul, Nipon Chattipakorn, and Siriporn C. Chattipakorn
Biomedicine & Pharmacotherapy
(2018)
97 :1663
